-

Capital Rx Named to Built In’s 2021 Best Places to Work Lists

Capital Rx recognized by Built In as Best Midsize Company to Work For and Best Place to Work NYC, and by EHIR for improving employee health, wellness, and productivity

NEW YORK--(BUSINESS WIRE)--Capital Rx (https://www.cap-rx.com/), the fastest-growing pharmacy benefit manager in the U.S., announced today that it was recognized by Built In as one of the Best Midsize Companies to Work For and New York City’s Best Places to Work.

Built In is an online community for startups and tech companies, with a focus on careers, tech news and events. Built In’s Best Places to Work awards are chosen based on compensation and employer benefits, including health and wellness, diversity and culture, and professional and social impact.

“We are humbled and honored to be recognized as one of the best midsize companies to work for, let alone one of the best companies to work for in New York City,” said Gurjeet Kashyap, Senior Vice President, People Operations at Capital Rx. “Our people are more than our most valuable asset; they are our extended family. We offer our employees the ability to innovate with us and provide them with comprehensive compensation, equity, and benefit plans, a fun and engaging culture, and a flexible work environment.”

In addition to being recognized by Built In, Capital Rx was presented the Employer Health Innovation Roundtable (EHIR) Traction Award at the end of 2020. EHIR is a coalition of large and progressive employers, and its semi-annual Traction Award recognizes innovative companies for advancing its mission to accelerate the adoption of innovation to improve the health, wellness and productivity of its employees. Traction Award winners are those with the most employer interest through EHIR’s match-making process.

“Receiving the EHIR traction award is a true testament to all of our employees’ hard work, not just in bringing transparency to drug pricing but in creating a great workplace collectively,” said AJ Loiacono, CEO at Capital Rx. “The work we all do in the interest of employers and their employees is demonstrated through these achievements, showing just how valuable our Clearinghouse Model is in pharmacy benefit management and to workplaces across the U.S.”

Capital Rx currently has 170 employees and is expected to grow substantially in 2021. To view open positions and learn more about Capital Rx, visit: https://cap-rx.com/careers.

About Capital Rx

Capital Rx is redefining the way prescriptions are priced and administered in the U.S. Through its Clearinghouse ModelSM, Capital Rx unlocks the pharmacy supply chain and reduces prescription costs for employer groups. By establishing a competitive marketplace for drug pricing, Capital Rx focuses its resources on deploying actionable strategies that improve plan performance and patient outcomes. The company’s commitment to innovation, technology, and service is why Capital Rx is the fastest-growing pharmacy benefit manager in America. For more information, please visit http://www.cap-rx.com.

Contacts

Genevieve Pasculli
Capital Rx
Phone: +1.646.878.6902
gpasculli@cap-rx.com

Media:
Sean Leous
Westwicke/ICR PR
Phone: +1.646.677.1839
sean.leous@icrinc.com

Capital Rx


Release Versions

Contacts

Genevieve Pasculli
Capital Rx
Phone: +1.646.878.6902
gpasculli@cap-rx.com

Media:
Sean Leous
Westwicke/ICR PR
Phone: +1.646.677.1839
sean.leous@icrinc.com

More News From Capital Rx

Capital Rx and 3 Axis Advisors Study Finds Potential for Billions in Prescription Drug Savings With Transparent Pricing Practices

NEW YORK--(BUSINESS WIRE)--Capital Rx, the fastest-growing pharmacy benefit manager in the U.S., announced today the results of a study that it commissioned with 3 Axis Advisors, which found that implementing transparent pricing practices via the National Average Drug Acquisition Cost (NADAC) benchmark has the potential to create billions of dollars in savings, and restore public trust in the U.S. drug pricing system. The full study results are available here. Potential legislative changes coul...

Capital Rx Named Winner of 2021 Edison Award

NEW YORK--(BUSINESS WIRE)--Capital Rx, the fastest-growing pharmacy benefit manager (PBM) in the U.S., announced today that its Clearinghouse ModelTM pricing framework has won a 2021 silver Edison Award. Named after Thomas Alva Edison, the Edison Awards have recognized and honored some of the most innovative new products, services, and business leaders in the world since 1987. Capital Rx created the Clearinghouse ModelTM to lower medication costs and bring pricing transparency to patients. Aban...

Capital Rx Crushes Net Promoter Score® and Receives 100 Percent-Positive Feedback on Client Implementation Satisfaction

NEW YORK--(BUSINESS WIRE)--Capital Rx announces a year-over-year increase in its Client NPS® from 2019 to 2020, and 100% positive feedback from new clients for 2021....
Back to Newsroom